Paul Perreault
Follow
Get notifications in MyBN when activity occurs.
Paul Perreault
Chief Executive, Managing Director / CSL
Paul Perreault has over 35 years of experience across the global biotech and pharmaceutical industries.
Prior to becoming chief executive and managing director of CSL in July 2013, he spent more than 15 years in key senior roles at Wyeth-Ayerst Laboratories (now part of Pfizer).
Mr Perreault holds a Bachelors degree in Psychology from the University of Central Florida, and completed Advanced Business Management training at the Kellogg and Wharton Schools of Business.
Prior to becoming chief executive and managing director of CSL in July 2013, he spent more than 15 years in key senior roles at Wyeth-Ayerst Laboratories (now part of Pfizer).
Mr Perreault holds a Bachelors degree in Psychology from the University of Central Florida, and completed Advanced Business Management training at the Kellogg and Wharton Schools of Business.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 523rd | CSL | 25% | 4% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | CSL | $22,343.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEWS: Tagged in CSL FY net profit dips to $A3.2bn | 17 Aug 2022 |
| NEWS: Tagged in CSL says vaccine manufacture accelerated | 18 Feb 2021 |
| NEWS: Tagged in Incentives drive executive pay | 02 Dec 2020 |
| NEW ROLE: Chief Executive, Managing Director, CSL | 03 Nov 2020 |
